Medulloblastoma

Evidence-based Pediatric Oncology: Second Edition

Volumn , Issue , 2007, Pages 125-149

  Ater, Joann ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cerebrospinal fluid (CSF); Chemotherapy; Medulloblastoma; Primitive neuroectodermal tumor (PNET); Radiotherapy

Indexed keywords

EID: 77952124360     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987148.ch7     Document Type: Chapter

References (25)

1. Rorke LB. Experimental production of primitive neuroectodermal tumors and its relevance to human neuro-oncology. Am J Pathol 1994;144:444-48.
2. Russo C, Pellarin M, Tingby O, Bollen AW, Lamborn KR, et al. Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors. Cancer 1999;86:331-39.
3. Zeltzer PM, Friedman HF, Norris DG, Ragab AH. Criteria and definitions for response and relapse in children with brain tumors. Cancer 1985;56:1824-26.
4. Gajjar A, Hernan R, Kocak M, Fuller C, Youngsoo L, et al. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol 2004;22:984-93.
5. Fernandez-Teijeiro A, Betensky RA, Sturla LM, Kim JYH, Tamayo P, Pomeroy SL. Combined gene expression profiles and clinical parameters for risk stratification in medulloblastomas. J Clin Oncol 2004;22:994-98.
6. Bloom HFG. Medulloblastoma in children: increasing survival rates and further prospects. Int J Radiat Oncol Biol Phys 1982;8:2023-27.
7. Pierce CA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. Studies of the mortality of atomic bomb survivo. Report 12, Part I. Cancer: 1950-90. Radiat Res 1996;146:1-27.
8. Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. Am J Roentgenol 2001;176:289-96.
9. Packer RJ, Sutton LN, Elterman R, et al.Outcome of children with medulloblastoma treated with radiation, cisplatin, CCNU and vincristine chemotherapy. J Neurosurg 1994; 81:690-98.
10. Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol 2005;23:7621-31.
11. Rutkowski S, Bode U, Deinlein F, Ottenmeier H, Warmuth-Metz M, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. New Engl J Med 2005;352:978-86.
12. Ater JL, van Eys J, Woo SY, Moore III B, Copeland D, Bruner J. MOPP chemotherapy without irradiation as primary post-surgical therapy for brain tumors in infants and young children. J Neurooncol 1997;32:243-52.
13. Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 2005;63:362-72.
14. Tait DM, Thornton Jones H, Bloom HJG, Lemerle V, Morris-Jones P. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP-I). Eur J Cancer 1990;26:464-9.
15. Bailey CC, Gneko A, Wellek S, Jones M, Round C, Brown J, et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP-II. Med Pediatr Oncol 1995;25:166-78.
16. Krischer JP, Ragab AH, Kun L, Kim TH, Laurent JP, Boyett JM, et al. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 1991;74:905-9.
17. Evans AE, Jerkin DT, Sposto R, Ortega JA, Wilson CB, Wara W, et al. Results of prospective randomised trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 1990;72:572-82.
18. Zeltzer PM, Boyett JM, Findlay JL, Albright L,Rorke LB, Milstein JM. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomised phase III study. J Clin Oncol 1999;17:832-45.
19. Cangir A, Ragab AH, Steuber P, Land VJ, Berry DH, Krischer JP. Combination chemotherapy with vincristine (NSC-67574), procarbazine (NSC-77213), prednisone with or without nitrogen mustard (NSC-762) (MOPP v OPP) in children with recurrent brain tumours.Med Pediatr Oncol 1984;12:1-3.
20. Deutsch M, Thomas PRM, Krischer J, Boyett JM, Albright L,Aronin P, et al. Results of a prospective randomised trial comparing standard dose neuraxis irradiation with reduced neuraxis irradiation in patients with low-stage medulloblastoma. Pediatr Neurosurg 1996;24:167-77.
21. Gerosa, M, DiStefano E, Carli M, Iraci G. Combined treatment of pediatric medulloblastoma. A review of an integrated program (two-arm chemotherapy trial). Child's Brain 1980;6:262-73.
22. Van Eys J, Chen T, Moore T, Cheek W, Sexauer C, Starling K. Adjuvant chemotherapy for medulloblastoma and ependymoma using IV vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Study Group. Cancer Treat Rep 1981;65:681-84.
23. Kortmann R-D, Kuhl J, Timmermann B, Mittler U, Urban C, Budach V, et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomised trial HIT '91. Int J Rad Oncol Biol Phys 2000;46:269-79.
24. Thomas P, Deutsch M,Kepner JL, Boyett JM,Krischer J, Aronin P, et al. Low stage medulloblastoma: final analysis of trial comparing standard-dose with reduceddose neuraxis irradiation. J Clin Oncol 2000;18:3004-11.
25. Taylor R, Bailey C, Robinson K, Weston C, Ellison D, Ironside J, et al. International Society of Paediatric Oncology; United Kingdom Children's Cancer Study Group. Results of a randomized study of pre radiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The international Society for Pediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol 2003;21: 1581-91.